搜索临床试验以:测试 2
总计25425个结果
-
GlaxoSmithKline完全的
-
GlaxoSmithKline完全的
-
Orion Corporation, Orion Pharma完全的
-
Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH完全的
-
M.D. Anderson Cancer CenterLeadiant Biosciences, Inc.完全的
-
Joseph TuscanoSpectrum Pharmaceuticals, Inc主动,不招人
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer Center完全的
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)NRG Oncology主动,不招人
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中IV 期前列腺癌 AJCC v8 | IVA 期前列腺癌 AJCC v8 | IVB 期前列腺癌 AJCC v8 | 转移性前列腺癌 | 去势敏感性前列腺癌美国
-
National Cancer Institute (NCI)主动,不招人头颈部鳞状细胞癌 | IV 期下咽鳞状细胞癌 AJCC v7 | IV 期喉鳞状细胞癌 AJCC v7 | IV 期口腔鳞状细胞癌 AJCC v6 和 v7 | IV 期口咽鳞状细胞癌 AJCC v7 | III 期下咽鳞状细胞癌 AJCC v7 | III 期喉鳞状细胞癌 AJCC v6 和 v7 | III 期口腔鳞状细胞癌 AJCC v6 和 v7 | III 期口咽鳞状细胞癌 AJCC v7 | 原发不明的头颈癌 | III 期鼻窦鳞状细胞癌 AJCC v6 和 v7 | IV 期鼻窦鳞状细胞癌 AJCC v7美国
-
National Cancer Institute (NCI)完全的Trebananib 联合或不联合 Bevacizumab、Pazopanib Hydrochloride、Sorafenib Tosylate 或 Sunitinib Malate 治疗晚期肾癌患者晚期肾细胞癌 | III 期肾细胞癌 AJCC v7 | IV 期肾细胞癌 AJCC v7 | 晚期肉瘤样肾细胞癌美国
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; GlaxoSmithKline; Beth Israel Deaconess Medical Center; Brigham and... 和其他合作者终止
-
Teva Branded Pharmaceutical Products R&D, Inc.招聘中
-
Dana-Farber Cancer InstituteGenentech, Inc.招聘中乳腺癌 | HER2阳性乳腺癌 | 激素受体阳性乳腺癌 | 浸润性乳腺癌 | 淋巴结阴性乳腺癌 | 微转移乳腺癌美国
-
Centre Hospitalier Departemental Vendee招聘中
-
Respirent Pharmaceuticals Co Ltd.Becro Ltd.完全的
-
Mundipharma Research Limited终止
-
University of SydneyNorthern Care Alliance NHS Foundation Trust; Waitemata District Health Board; Australasian Kidney...招聘中
-
Hospital for Special Surgery, New YorkChildren's Healthcare of Atlanta; Campbell Clinic; Pediatric Orthopaedic Society of North America 和其他合作者招聘中